share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4：持股變動聲明-高管 BOURLA ALBERT
美股sec公告 ·  07/02 01:18
牛牛AI助理已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on 06/28/2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction reflects the ongoing financial activities of Pfizer's top executives and may be of interest to investors monitoring insider actions within the company.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on 06/28/2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Bourla after the transaction. The transaction reflects the ongoing financial activities of Pfizer's top executives and may be of interest to investors monitoring insider actions within the company.
輝瑞公司（PFE）董事長兼CEO艾伯特·布洛拉於2024年6月28日進行了一項交易。公告未披露交易涉及的股份數量、股份性質、交易價格和股份總價值的具體細節。報告也未提供布洛拉交易後持有的股份數量信息。該交易反映了輝瑞公司高管的持續財務活動，可能引起投資者對公司內部交易動態的關注。
輝瑞公司（PFE）董事長兼CEO艾伯特·布洛拉於2024年6月28日進行了一項交易。公告未披露交易涉及的股份數量、股份性質、交易價格和股份總價值的具體細節。報告也未提供布洛拉交易後持有的股份數量信息。該交易反映了輝瑞公司高管的持續財務活動，可能引起投資者對公司內部交易動態的關注。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。